Received May 9, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAPIPVHIB | DTAP + IPV + HIB (PENTACEL) | SANOFI PASTEUR | UNK | UK199AA | IM / LL |
| PNC20 | PNEUMO (PREVNAR20) | PFIZER\WYETH | UNK | LK6653 | IM / RL |
Patient given Pentacel vaccine. Which consist of DTap, IPV & Hib. Patient did not receive Hib portion of vaccine. Manufacturer of vaccine Sanofi Paseur consulted. Writer instructed to give HIB portion of vaccine with 0.4% Chloride, no time frame recommended. Patient has no known signs or symptoms, or adverse reactions over the course of incident. Patients' legal guardian will be notified of diversion and instructed to bring patient into clinic to receive HIB portion of vaccine Staff retrained on how to properly administer vaccine to prevent future mistakes.
None known
Hydronephrosis, left Infant of mother with gestational diabetes mellitus (GDM) Kidney abnormality of fetus on prenatal ultrasound (HHS-HCC) Multicystic dysplastic kidney (MCDK)
cetirizine (ZYRTEC) 1 mg/mL syrup Take 2.5 mL by mouth once daily clotrimazole (LOTRIMIN) 1 % cream Apply topically hydrocortisone 2.5 % ointment Apply topically 2 (two) times daily mupirocin (BACTROBAN) 2 % ointment Apply 1 g topical
No known allergies
None known